Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
H Zhou, L Zhu, J Song, G Wang, P Li, W Li, P Luo… - Molecular cancer, 2022 - Springer
Colorectal cancer (CRC) is one of the most common cancers worldwide and a leading
cause of carcinogenic death. To date, surgical resection is regarded as the gold standard by …
cause of carcinogenic death. To date, surgical resection is regarded as the gold standard by …
A review of circulating tumour cell enrichment technologies
AJ Rushton, G Nteliopoulos, JA Shaw, RC Coombes - Cancers, 2021 - mdpi.com
Simple Summary Circulating tumour cells (CTCs) are cancer cells shed into the bloodstream
from tumours and their analysis can provide important insights into cancer detection and …
from tumours and their analysis can provide important insights into cancer detection and …
Nanotechnology strategies to advance outcomes in clinical cancer care
Ongoing research into the application of nanotechnology for cancer treatment and diagnosis
has demonstrated its advantages within contemporary oncology as well as its intrinsic …
has demonstrated its advantages within contemporary oncology as well as its intrinsic …
Targeted therapies for renal cell carcinoma
EM Posadas, S Limvorasak, RA Figlin - Nature Reviews Nephrology, 2017 - nature.com
The management of patients with metastatic renal cell carcinoma (RCC) has changed
dramatically over the past few years. Nephrectomy remains an important intervention for …
dramatically over the past few years. Nephrectomy remains an important intervention for …
Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer …
Importance Preferential delivery of docetaxel to tumors by prostate-specific membrane
antigen (PSMA)–targeted nanoparticles is clinically effective, and the selective reduction of …
antigen (PSMA)–targeted nanoparticles is clinically effective, and the selective reduction of …
Tumour heterogeneity: the key advantages of single-cell analysis
M Tellez-Gabriel, B Ory, F Lamoureux… - International journal of …, 2016 - mdpi.com
Tumour heterogeneity refers to the fact that different tumour cells can show distinct
morphological and phenotypic profiles, including cellular morphology, gene expression …
morphological and phenotypic profiles, including cellular morphology, gene expression …
Nanostructured substrates for detection and characterization of circulating rare cells: from materials research to clinical applications
Circulating rare cells in the blood are of great significance for both materials research and
clinical applications. For example, circulating tumor cells (CTCs) have been demonstrated …
clinical applications. For example, circulating tumor cells (CTCs) have been demonstrated …
Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells
We present a critical review of microfluidic technologies and material effects on the analyses
of circulating tumour cells (CTCs) selected from the peripheral blood of cancer patients …
of circulating tumour cells (CTCs) selected from the peripheral blood of cancer patients …
[HTML][HTML] Circulating tumor cells: moving biological insights into detection
Circulating tumor cells (CTCs) have shown promising potential as liquid biopsies that
facilitate early detection, prognosis, therapeutic target selection and monitoring treatment …
facilitate early detection, prognosis, therapeutic target selection and monitoring treatment …
Concise review: prostate cancer stem cells: current understanding
Prostate cancer (PCa) is heterogeneous, harboring phenotypically diverse cancer cell types.
PCa cell heterogeneity is caused by genomic instability that leads to the clonal competition …
PCa cell heterogeneity is caused by genomic instability that leads to the clonal competition …